A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation

MLA

Daniel B. Reeves, et al. “A Majority of HIV Persistence during Antiretroviral Therapy Is Due to Infected Cell Proliferation.” Nature Communications, vol. 9, no. 1, Nov. 2018, pp. 1–16. EBSCOhost, https://doi.org/10.1038/s41467-018-06843-5.

APA

Daniel B. Reeves, Elizabeth R. Duke, Thor A. Wagner, Sarah E. Palmer, Adam M. Spivak, & Joshua T. Schiffer. (2018). A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation. Nature Communications, 9(1), 1–16. https://doi.org/10.1038/s41467-018-06843-5

Chicago

Daniel B. Reeves, Elizabeth R. Duke, Thor A. Wagner, Sarah E. Palmer, Adam M. Spivak, and Joshua T. Schiffer. 2018. “A Majority of HIV Persistence during Antiretroviral Therapy Is Due to Infected Cell Proliferation.” Nature Communications 9 (1): 1–16. doi:10.1038/s41467-018-06843-5.